These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8295214)
21. Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate. Goldin SM; Subbarao K; Sharma R; Knapp AG; Fischer JB; Daly D; Durant GJ; Reddy NL; Hu LY; Magar S Ann N Y Acad Sci; 1995 Sep; 765():210-29. PubMed ID: 7486608 [TBL] [Abstract][Full Text] [Related]
22. Tetrapentylammonium block of chloramine-T and veratridine modified rat brain type IIA sodium channels. Ghatpande AS; Rao S; Sikdar SK Br J Pharmacol; 2001 Apr; 132(8):1755-60. PubMed ID: 11309247 [TBL] [Abstract][Full Text] [Related]
23. Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells. Yanagita T; Maruta T; Uezono Y; Satoh S; Yoshikawa N; Nemoto T; Kobayashi H; Wada A Neuropharmacology; 2007 Dec; 53(7):881-9. PubMed ID: 17950380 [TBL] [Abstract][Full Text] [Related]
24. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists. Chidlow G; Melena J; Osborne NN Br J Pharmacol; 2000 Jun; 130(4):759-66. PubMed ID: 10864881 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Deffois A; Fage D; Carter C Neurosci Lett; 1996 Dec; 220(2):117-20. PubMed ID: 8981487 [TBL] [Abstract][Full Text] [Related]
27. Blockade of voltage-sensitive Na(+) channels by the 5-HT(1A) receptor agonist 8-OH-DPAT: possible significance for neuroprotection. Melena J; Chidlow G; Osborne NN Eur J Pharmacol; 2000 Oct; 406(3):319-24. PubMed ID: 11040337 [TBL] [Abstract][Full Text] [Related]
28. Anaerobic glycolysis and postanoxic recovery of respiration of rat cortical synaptosomes are reduced by synaptosomal sodium load. Gleitz J; Beile A; Khan S; Wilffert B; Tegtmeier F Brain Res; 1993 May; 611(2):286-94. PubMed ID: 8334522 [TBL] [Abstract][Full Text] [Related]
29. Na(+) channel effects of remacemide and desglycinyl-remacemide in rat cortical synaptosomes. Santangeli S; Sills GJ; Thompson GG; Brodie MJ Eur J Pharmacol; 2002 Mar; 438(1-2):63-8. PubMed ID: 11906711 [TBL] [Abstract][Full Text] [Related]
30. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence. Callaway JK; Castillo-Melendez M; Giardina SF; Krstew EK; Beart PM; Jarrott B Neuropharmacology; 2004 Jul; 47(1):146-55. PubMed ID: 15165842 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels. Ratnakumari L; Vysotskaya TN; Duch DS; Hemmings HC Anesthesiology; 2000 Feb; 92(2):529-41. PubMed ID: 10691242 [TBL] [Abstract][Full Text] [Related]
32. 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models. Macsari I; Besidski Y; Csjernyik G; Nilsson LI; Sandberg L; Yngve U; Ahlin K; Bueters T; Eriksson AB; Lund PE; Venyike E; Oerther S; Hygge Blakeman K; Luo L; Arvidsson PI J Med Chem; 2012 Aug; 55(15):6866-80. PubMed ID: 22770500 [TBL] [Abstract][Full Text] [Related]
33. Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs. Ashton D; Willems R; Wynants J; Van Reempts J; Marrannes R; Clincke G Brain Res; 1997 Jan; 745(1-2):210-21. PubMed ID: 9037412 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of Na+ channels by the novel blocker PD85,639. Ragsdale DS; Numann R; Catterall WA; Scheuer T Mol Pharmacol; 1993 Jun; 43(6):949-54. PubMed ID: 8391119 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological evaluation of 2-(1-alkylpiperidin-4-yl)-n-[(1r)-1-(4-fluorophenyl)-2-methylpropyl]acetamide Derivatives as Novel Antihypertensive Agents. Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S Chem Pharm Bull (Tokyo); 2012; 60(2):223-34. PubMed ID: 22293482 [TBL] [Abstract][Full Text] [Related]
36. Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides. Cumming JG; Cooper AE; Grime K; Logan CJ; McLaughlin S; Oldfield J; Shaw JS; Tucker H; Winter J; Whittaker D Bioorg Med Chem Lett; 2005 Nov; 15(22):5012-5. PubMed ID: 16154744 [TBL] [Abstract][Full Text] [Related]